Plasma cell leukemia (PCL) is a rare disease that may present de novoor secondary to plasma cell myeloma. Advanced disease and extramedullary involvement are common clinical features at presentation.

Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that ...

The three-dimensional structure of DNA in the nucleus is stabilized ... architecture to drive gene regulation in acute ...

Chronic lymphocytic leukemia (CLL) is a slow-growing cancer that affects white blood cells. Survival rates tend to be high, but these may vary. Leukemia is a type of cancer involving human blood ...

Changes in Blood Cell Production Over the Lifetime Could Impact Leukemia Outcomes Dec. 5, 2024 — The first comprehensive map of the dramatic changes that take place in the blood system over the ...

In aggressive cases of leukemia, the only chance ... to a cytotoxic drug recognize all blood cells in the patient's body based on a surface structure. This marker is common to all the different ...

For people with hairy cell leukemia (HCL), a healthy diet may help strengthen and support the immune system, which may help keep the condition under control. HCL is a rare leukemia that affects ...

Bioinformatics and experimental validation have revealed 179 shared differentially expressed genes (DEGs) between chronic lymphocytic leukemia (CLL) and diffuse large B-cell lymphoma (DLBCL), ...

B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most ...